| Zdroj: |
Cancer Weekly; 5/2/2023, p789-789, 1p |
| Abstrakt: |
The association between sEV-GCC2 and lung adenocarcinoma remained after adjustment for pathological TNM stage and tumor location in the left lower lobe. SEV-GCC2 represents a promising therapeutic target for lung adenocarcinoma and may be quantified as key molecules in the progression of lung adenocarcinoma. Keywords: Adenocarcinoma; Cancer; Cell Proliferation; Diagnostics and Screening; Drugs and Therapies; Health and Medicine; Lung Cancer; Lung Diseases and Conditions; Lung Neoplasms; Oncology EN Adenocarcinoma Cancer Cell Proliferation Diagnostics and Screening Drugs and Therapies Health and Medicine Lung Cancer Lung Diseases and Conditions Lung Neoplasms Oncology 789 789 1 05/02/23 20230502 NES 230502 2023 MAY 2 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Fresh data on lung cancer are presented in a new report. [Extracted from the article] |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
